Irloxacin
Alternative Names: E 3432Latest Information Update: 17 Feb 2006
At a glance
- Originator Esteve
- Developer Esteve; Innothera
- Class Antibacterials; Quinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Obstetric and gynaecological infections
Most Recent Events
- 16 Oct 1998 Suspended-III for Bacterial infections in Spain (Topical)
- 29 May 1998 Suspended-preclinical phase for Obstetric and gynaecological infections in France (Unknown route)
- 30 Jul 1996 Phase-III clinical trials for Bacterial infections in Spain (Topical)